Khatri, A., Suleiman, A. A., Polepally, A. R., & Othman, A. A. (2019). Exposure–Response Relationships for Efficacy and Safety of Risankizumab in Phase II and III Trials in Psoriasis Patients. Clin Pharmacol Ther.
Citação norma ChicagoKhatri, Amit, Ahmed A. Suleiman, Akshanth R. Polepally, and Ahmed A. Othman. "Exposure–Response Relationships for Efficacy and Safety of Risankizumab in Phase II and III Trials in Psoriasis Patients." Clin Pharmacol Ther 2019.
Deismireacht MLAKhatri, Amit, Ahmed A. Suleiman, Akshanth R. Polepally, and Ahmed A. Othman. "Exposure–Response Relationships for Efficacy and Safety of Risankizumab in Phase II and III Trials in Psoriasis Patients." Clin Pharmacol Ther 2019.
Rabhadh: D'fhéadfadh nach mbeadh na deismireachtaí seo 100% cruinn i gcónaí.